CMS 34th Anniversary | Moving with Time, Growing for Tomorrow

Thirty-four years have been a journey of walking side by side, preserved in photographs, and a process of building solid foundations step by step for future breakthroughs. Every captured moment is etched with the mark of CMSer: pragmatic and hardworking, rising to challenges, and striving for breakthroughs and progress. These accumulated achievements are not only a testament we can look back on, but also the confidence and strength that enable CMS to navigate cycles and continue growing upward.

Since 2018, CMS has initiated a transformation of growth momentum with innovation at its core, driving a systematic upgrade of its development model. The Group has remained guided by clinical needs, centered on product value, and supported by system capabilities. It has built differentiated innovation pipelines through multiple pathways and strengthened full-lifecycle management capabilities. CMS has enhanced commercialization efficiency through the collaboration between deep specialty focus and omni-channel marketing, and has promoted organizational evolution through AI-enabled digital intelligence. At the same time, the Group has accelerated its presence in emerging markets, continuously expanding the space and boundaries of industry development. Through this process, CMS has not only reshaped its capabilities, but has also steadily crystallized a forward-looking growth thesis.

At this new starting point of the 34th anniversary, the vision of a “New CMS” is becoming ever clearer. With innovation-driven development as the underlying logic, CMS is building a solid foundation for steady growth through a diversified business ecosystem, while opening broader development horizons through industrial internationalization. Looking ahead, CMS will maintain stronger strategic resolve, continue to strengthen system capabilities and expand the boundaries of value, and achieve long-term, high-quality growth through ongoing evolution, continually unlocking new possibilities.